Hero image

ABOUT US

Empowering Pharmaceutical Development with AI

At Revilico, we specialize in providing innovative Physics Driven AI solutions with our End-to-End Discovery Platform.

At Revilico, we specialize in providing innovative Physics Driven AI solutions with our End-to-End Discovery Platform.

HOW IT WORKS

Our Journey Towards
Technological Excellence

Our mission is to transform pharmaceutical development by dramatically reducing costs and time, empowering researchers to bring life-changing therapies to market with speed and precision.

01

Efficiency

Streamlined workflows powered by AI to accelerate drug discovery, from target identification to lead optimization.

02

Reliability

A robust and validated platform ensuring trustworthy insights for therapeutic development.

03

Innovation

Redefining small molecule drug discovery with breakthrough AI, generative models, and predictive analytics.

04

Integration

Seamlessly integrates with your research pipeline and strategy, enhancing productivity without disruption.

97%

Reduction in Chemical Search Space

Reduction in Chemical Search Space

Reduction in Chemical Search Space

85%

Threshold Acceptable Accuracy across all Models

Threshold Acceptable Accuracy across all Models

Threshold Acceptable Accuracy across all Models

70B

Molecules Available to Screen with AI

Molecules Available to Screen with AI

Molecules Available to Screen with AI

80%

Projected Cost Reduction Every Campaign

Projected Cost Reduction Every Campaign

Projected Cost Reduction Every Campaign

Meet Our Team

Meet Our Team

Christopher Korban

Chief Executive Officer

Christopher Korban

Chief Executive Officer

Christopher Korban

Chief Executive Officer

Christian Chung

Chief Scientific Officer

Christian Chung

Chief Scientific Officer

Christian Chung

Chief Scientific Officer

Al Rahrooh

Chief Technical Officer

Al Rahrooh

Chief Technical Officer

Al Rahrooh

Chief Technical Officer

Aryan Kohli

VP of Research and Development

Aryan Kohli

VP of Research and Development

Aryan Kohli

VP of Research and Development

Mohammed Danish

VP of Business Development

Mohammed Danish

VP of Business Development

Mohammed Danish

VP of Business Development

Omar Fayaz

Lead AI Engineer

Omar Fayaz

Lead AI Engineer

Omar Fayaz

Lead AI Engineer

Sarah Fisher

Bioengineer

Sarah Fisher

Bioengineer

Sarah Fisher

Bioengineer

Balkrushna More

Senior Software Engineer

Balkrushna More

Senior Software Engineer

Balkrushna More

Senior Software Engineer

Tejaswan Kalluri

Software Engineer

Tejaswan Kalluri

Software Engineer

Tejaswan Kalluri

Software Engineer

Kristoffer Alejo

Bioengineer

Kristoffer Alejo

Bioengineer

Kristoffer Alejo

Bioengineer

Hetvi Trivedi

Bioengineer

Hetvi Trivedi

Bioengineer

Hetvi Trivedi

Bioengineer

Our Board of Advisors

Our Board of Advisors

Tom Lobl, PhD

Chair, Board of Advisors

Tom Lobl, PhD

Chair, Board of Advisors

Tom Lobl, PhD

Chair, Board of Advisors

Terry Kramer, MBA

Senior Business Advisor

Terry Kramer, MBA

Senior Business Advisor

Terry Kramer, MBA

Senior Business Advisor

Callie Fredlender, PhD

Science Advisor

Callie Fredlender, PhD

Science Advisor

Callie Fredlender, PhD

Science Advisor

Ryan Wei, MBA

Business Advisor

Ryan Wei, MBA

Business Advisor

Ryan Wei, MBA

Business Advisor

Harald Nuhn, PhD

Science Advisor

Harald Nuhn, PhD

Science Advisor

Harald Nuhn, PhD

Science Advisor

Hannaneh Hojaiji, PhD

Science Advisor

Hannaneh Hojaiji, PhD

Science Advisor

Hannaneh Hojaiji, PhD

Science Advisor

Marcella Scaccia, MD

Clinical Advisor

Marcella Scaccia, MD

Clinical Advisor

Marcella Scaccia, MD

Clinical Advisor